158 related articles for article (PubMed ID: 2161789)
1. Immunohistochemical staining of Ha-ras oncogene product in normal, benign, and malignant human pancreatic tissues.
Shimizu M; Saitoh Y; Itoh H
Hum Pathol; 1990 Jun; 21(6):607-12. PubMed ID: 2161789
[TBL] [Abstract][Full Text] [Related]
2. The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions.
Kuroda N; Toi M; Nakayama H; Miyazaki E; Yamamoto M; Hayashi Y; Hiroi M; Enzan H
Histol Histopathol; 2004 Jan; 19(1):59-67. PubMed ID: 14702172
[TBL] [Abstract][Full Text] [Related]
3. CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions.
Barth PJ; Ebrahimsade S; Hellinger A; Moll R; Ramaswamy A
Virchows Arch; 2002 Feb; 440(2):128-133. PubMed ID: 11964041
[TBL] [Abstract][Full Text] [Related]
4. COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer.
Liao Q; Kleeff J; Xiao Y; Di Cesare PE; Korc M; Zimmermann A; Büchler MW; Friess H
Scand J Gastroenterol; 2003 Feb; 38(2):207-15. PubMed ID: 12678339
[TBL] [Abstract][Full Text] [Related]
5. Differential MUC 1 expression in normal and neoplastic human pancreatic tissue. An immunohistochemical study of 60 samples.
Monges GM; Mathoulin-Portier MP; Acres RB; Houvenaeghel GF; Giovannini MF; Seitz JF; Bardou VJ; Payan MJ; Olive D
Am J Clin Pathol; 1999 Nov; 112(5):635-40. PubMed ID: 10549250
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pancreatitis due to tiny (0.6 to 8 mm) benign tumors obstructing pancreatic ducts: report of three cases.
Sarles H; Cambon P; Choux R; Payan MJ; Odaira S; Laugier R; Sahel J
Pancreas; 1988; 3(2):232-7. PubMed ID: 2836852
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
8. Acinar cell cystadenoma of the pancreas: a benign neoplasm or non-neoplastic ballooning of acinar and ductal epithelium?
Singhi AD; Norwood S; Liu TC; Sharma R; Wolfgang CL; Schulick RD; Zeh HJ; Hruban RH
Am J Surg Pathol; 2013 Sep; 37(9):1329-35. PubMed ID: 24076773
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ki-67, p53, and K-ras in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Jeong S; Lee DH; Lee JI; Lee JW; Kwon KS; Kim PS; Kim HG; Shin YW; Kim YS; Kim YB
World J Gastroenterol; 2005 Nov; 11(43):6765-9. PubMed ID: 16425381
[TBL] [Abstract][Full Text] [Related]
10. Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions.
Xerri L; Payan MJ; Choux R; Gros N; Figarella-Branger D; Sarles H
Hum Pathol; 1990 Sep; 21(9):927-31. PubMed ID: 1697555
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis.
Apple SK; Hecht JR; Lewin DN; Jahromi SA; Grody WW; Nieberg RK
Hum Pathol; 1999 Feb; 30(2):123-9. PubMed ID: 10029438
[TBL] [Abstract][Full Text] [Related]
12. Ductal origin of pancreatic adenocarcinomas induced by conditional activation of a human Ha-ras oncogene in rat pancreas.
Ueda S; Fukamachi K; Matsuoka Y; Takasuka N; Takeshita F; Naito A; Iigo M; Alexander DB; Moore MA; Saito I; Ochiya T; Tsuda H
Carcinogenesis; 2006 Dec; 27(12):2497-510. PubMed ID: 16774944
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical staining of pancreatic cancer with CA19-9, KM01, unabsorbed CEA, and absorbed CEA. A comparison with normal pancreas and chronic pancreatitis.
Shimizu M; Saitoh Y; Ohyanagi H; Itoh H
Arch Pathol Lab Med; 1990 Feb; 114(2):195-200. PubMed ID: 1689141
[TBL] [Abstract][Full Text] [Related]
14. Expression of MUC apomucins in normal pancreas and pancreatic tumours.
Terada T; Ohta T; Sasaki M; Nakanuma Y; Kim YS
J Pathol; 1996 Oct; 180(2):160-5. PubMed ID: 8976874
[TBL] [Abstract][Full Text] [Related]
15. [Endocrine component of exocrine pancreatic tumors. Apropos of 2 cases].
Kusielewicz D; Houry S; Sabourin JC; Georges O; Roland J; Huguier M; Bodin F
Ann Gastroenterol Hepatol (Paris); 1992; 28(1):12-6. PubMed ID: 1313217
[TBL] [Abstract][Full Text] [Related]
16. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic acinar cell carcinomas with prominent ductal differentiation: Mixed acinar ductal carcinoma and mixed acinar endocrine ductal carcinoma.
Stelow EB; Shaco-Levy R; Bao F; Garcia J; Klimstra DS
Am J Surg Pathol; 2010 Apr; 34(4):510-8. PubMed ID: 20182344
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of pancreatic ductal adenocarcinoma compared with normal adjacent pancreatic tissue and pancreatic benign cystadenoma.
Cui Y; Tian M; Zong M; Teng M; Chen Y; Lu J; Jiang J; Liu X; Han J
Pancreatology; 2009; 9(1-2):89-98. PubMed ID: 19077459
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.
Song MM; Nio Y; Sato Y; Tamura K; Furuse K
Int J Pancreatol; 1996 Oct; 20(2):85-93. PubMed ID: 8968863
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic mixed ductal-islet tumors. Is this an entity?
Permert J; Mogaki M; Andrén-Sandberg A; Kazakoff K; Pour PM
Int J Pancreatol; 1992 Feb; 11(1):23-9. PubMed ID: 1316418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
